These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 15307884)

  • 1. Adefovir dipivoxil to prevent exacerbation of lamivudine-resistant hepatitis B infection during chemotherapy for non-Hodgkin's lymphoma.
    Enomoto M; Nishiguchi S; Seki S; Yamane T; Hino M
    Am J Gastroenterol; 2004 Aug; 99(8):1619-20. PubMed ID: 15307884
    [No Abstract]   [Full Text] [Related]  

  • 2. Severe exacerbation of chronic hepatitis B after emergence of lamivudine resistance in a cirrhotic patient: immediate switch to adefovir dipivoxil appears to be indicated.
    Wiegand J; Tischendorf JJ; Nashan B; Klempnauer J; Flemming P; Niemann P; Rohde P; Manns MP; Trautwein C; Tillmann HL
    Z Gastroenterol; 2004 Jan; 42(1):15-8. PubMed ID: 14997399
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Successful treatment of fibrosing cholestatic hepatitis using adefovir dipivoxil in a patient with cirrhosis and renal insufficiency.
    Tillmann HL; Bock CT; Bleck JS; Rosenau J; Böker KH; Barg-Hock H; Becker T; Trautwein C; Klempnauer J; Flemming P; Manns MP
    Liver Transpl; 2003 Feb; 9(2):191-6. PubMed ID: 12548514
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Adefovir-lamivudine combination therapy and hepatitis B viral kinetics.
    Mutimer D
    J Hepatol; 2005 Aug; 43(2):200-2. PubMed ID: 15975684
    [No Abstract]   [Full Text] [Related]  

  • 5. Adefovir dipivoxil as a treatment for hepatic failure caused by lamivudine-resistant HBV strains.
    Kuwahara R; Kumashiro R; Inoue H; Tanabe R; Tanaka E; Hino T; Ide T; Koga Y; Sata M
    Dig Dis Sci; 2004 Feb; 49(2):300-3. PubMed ID: 15104374
    [No Abstract]   [Full Text] [Related]  

  • 6. Hepatitis B virus kinetics and mathematical modeling.
    Perelson AS; Ribeiro RM
    Semin Liver Dis; 2004; 24 Suppl 1():11-6. PubMed ID: 15192796
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-term therapy with adefovir dipivoxil in hepatitis B e antigen-negative patients developing resistance to lamivudine.
    Manolakopoulos S; Bethanis S; Koutsounas S; Goulis J; Vlachogiannakos J; Christias E; Saveriadis A; Pavlidis C; Triantos C; Christidou A; Papatheodoridis G; Karamanolis D; Tzourmakliotis D
    Aliment Pharmacol Ther; 2008 Feb; 27(3):266-73. PubMed ID: 17988233
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mutations associated with the therapeutic efficacy of adefovir dipivoxil added to lamivudine in patients resistant to lamivudine with type B chronic hepatitis.
    Ohkawa K; Takehara T; Kato M; Kanada A; Deguchi M; Kagita M; Hikita H; Sasakawa A; Kohga K; Uemura A; Sakamori R; Yamaguchi S; Miyagi T; Ishida H; Tatsumi T; Hayashi N
    J Med Virol; 2009 May; 81(5):798-806. PubMed ID: 19319954
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Controversies about the treatment of hepatitis B (lamivudine, interferon, a combination or more?).
    Desai HG; Chowdhury A
    Trop Gastroenterol; 2003; 24(3):157-60. PubMed ID: 14978995
    [No Abstract]   [Full Text] [Related]  

  • 10. Management of patients with decompensated HBV cirrhosis.
    Fontana RJ
    Semin Liver Dis; 2003 Feb; 23(1):89-100. PubMed ID: 12616454
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment of patients with lamivudine-resistant and adefovir dipivoxil-resistant chronic hepatitis B virus infection: is tenofovir the answer?
    Trojan J; Stuermer M; Teuber G; Berger A; Faust D
    Gut; 2007 Mar; 56(3):436-7; author reply 437. PubMed ID: 17339249
    [No Abstract]   [Full Text] [Related]  

  • 12. Successful long-term control with lamivudine against reactivated hepatitis B infection following intensive chemotherapy and autologous peripheral blood stem cell transplantation in non-Hodgkin's lymphoma: experience of 2 cases.
    Nakagawa M; Simizu Y; Suemura M; Sato B
    Am J Hematol; 2002 May; 70(1):60-3. PubMed ID: 11994984
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dynamics of lamivudine-resistant hepatitis B virus during adefovir monotherapy versus lamivudine plus adefovir combination therapy.
    Ijaz S; Arnold C; Dervisevic S; Mechurova J; Tatman N; Tedder RS; Naoumov NV
    J Med Virol; 2008 Jul; 80(7):1160-70. PubMed ID: 18461609
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Virological response and incidence of adefovir resistance in lamivudine-resistant patients treated with adefovir dipivoxil.
    Chen CH; Wang JH; Lee CM; Hung CH; Hu TH; Wang JC; Lu SN; Changchien CS
    Antivir Ther; 2006; 11(6):771-8. PubMed ID: 17310821
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Efficacy and safety of adefovir dipivoxil in patients with decompensated liver cirrhosis with Lamivudine resistance compared to patients with compensated liver disease].
    Moon W; Choi MS; Moon YM; Paik SW; Lee JH; Koh KC; Yoo BC; Rhee JC; Shim SG
    Korean J Hepatol; 2005 Jun; 11(2):125-34. PubMed ID: 15980671
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment of lamivudine-resistant hepatitis B infection in post-renal transplant patients with adefovir dipivoxil: preliminary results.
    de Silva HJ; Dassanayake AS; Manamperi A; de Silva AP
    Transplant Proc; 2006 Nov; 38(9):3118-20. PubMed ID: 17112914
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Adefovir dipivoxil therapy in liver transplant recipients with lamivudine-resistant hepatitis B virus.
    Herreros de Tejada Echanojáuregui A; Moreno Planas JM; Rubio González E; Portero Azorin F; López Monclús J; Revilla Negro J; Lucena de la Poza JL; Sánchez Turrión V; Barrios Peinado C; Cuervas-Mons Martínez V
    Transplant Proc; 2005 Apr; 37(3):1507-8. PubMed ID: 15866657
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Lamivudine and adefovir dipivoxil combination treatment for liver cirrhosis patients with CHB].
    Yang DH; Xie SF; Wang YM; Zhao NF; Li MW
    Zhonghua Gan Zang Bing Za Zhi; 2008 Jun; 16(6):473-4. PubMed ID: 18579006
    [No Abstract]   [Full Text] [Related]  

  • 19. Adefovir dipivoxil for wait-listed and post-liver transplantation patients with lamivudine-resistant hepatitis B: final long-term results.
    Schiff E; Lai CL; Hadziyannis S; Neuhaus P; Terrault N; Colombo M; Tillmann H; Samuel D; Zeuzem S; Villeneuve JP; Arterburn S; Borroto-Esoda K; Brosgart C; Chuck S;
    Liver Transpl; 2007 Mar; 13(3):349-60. PubMed ID: 17326221
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Adefovir treatment in posttransplant hepatitis B virus infection resistant to lamivudine plus hepatitis B virus immunoglobulin.
    Akay S; Karasu Z; Akyildiz M; Tokat Y
    Transplant Proc; 2004 Nov; 36(9):2768-70. PubMed ID: 15621144
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.